TFAP4 was found to be an independent prognostic indicator for OS and DFS in HCC patients (HR, 2.712; 95% CI, 1.705-4.314; HR, 2.086; 95% CI, 1.450-3.001, respectively). The gene discussed is TFAP4; the disease is hepatocellular carcinoma.